Применение куркумина в дерматологии

Литература:
1. Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma Longa: A review of preclinical and clinical research. Alternative Medicine Review 2009; 14 (2): 141-153
2. Sintov AC. Transdermal delivery of curcumin via microemulsion. International Journal of Pharmaceutics 2015; 481:97-103
3. Ammon HP, Wahl MA. Pharmacology of Curcuma Longa. PlantaMed 1991; 57: I-7
4. Lampe V, Milobedzka J. No title available. Ber Dtsch Chem Ces 1913; 46: 2235
5. Akbik D, Ghadiri M, Chrzanowski W, Rohanizadeh R. Curcumin as a wound healing agent. Life Sciences 2014; 116(1): 1-7
6. Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee R. Turmeric and curcumin: biological actions and medicinal applications. Curr Sci 2004; 87: 44-53
7. Lestari MLAD, Indrayanto G. Curcumin. Profiles of Drug Substances, Excipients and Related Methodology 2014; 39: 113-204
8. Anamika B. Extraction of curcumin. J Environ Sci Toxicol Food Technol 2012; 1: 1-16
9. Cashman JR, Ghirmai S, Abel KJ, Fiala M. Immune defects in Alzheimer's disease: new medications development. ВМС Neuroscience 2008; 9 (Suppl 2): S13
10. Tonnesen HH, Karlsen J, Henegouwen GBV. Studies on curcumin and curcuminoids VII. Kinetics of curcumin degradation in aqueous solution. Z Lebensm Unters Forsch 1985; 180:402-404
11. Wang YJ, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997; 15: 1867-1876
12. Tonnesen HH, Karlsen J, Henegouwen GBV. Studies on curcumin and curcuminoids VIII. Photochemical stability of curcumin. Z Lebensm Unters Forsch 1986; 183: 116-122
13. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of Curcumin: Problems and Promises. Molecular Pharmaceutics 2007; 4 (6): 807-818
14. Padmanaban G, Rangarajan PN. Curcumin as an adjunct drug for infectious diseases. Trends in Pharmacological Sciences 2016; 37 (1): 1-3
15. Kulkarni SK, Dhir A An overview of curcumin in neurological disorders. Indian J Pharm Sci 2010; 72 (2): 149-154
16. Silva AP, Carbinatto FM, Bagnato VS, Inada NM. A promising strategy for the treatment of onychomycosis with curcumin and photodynamic therapy. Journal of Pharmacy and Pharmacology 2015; 3: 434-437
17. Silva AP, Carbinatto FM, Bagnato VS, Inada NM. New strategies for treatment of onychomycosis. Photodiagnosis and Photodynamic Therapy 2015; 12: 325-375
18. Kurd SK, et al. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial.. Am Acad Dermatol 2008; 58 (4): 625-631
19. Antiga E, Bonciolini V, Volpi W, Bianco ED, Caproni M. Oral curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris. Bio Med Research International 2015; 2015: 1-7
20. Утц С. P., Галкина E.M., Райгородский Ю.М. Синий и красный свет в терапии акне (обзор). Саратовский научно-медицинский журнал 2013; 9 (3): 577-582
21. Calabro G, Patalano A, Conte VN, Chianese С. Photodynamic chemotherapy in the treatment of superficial mycoses: an evidence-based evaluation. G Ital Dermatol Venereal 2013; 148: 639-48
22. Baltazar LM, et al. Antimicrobial photodynamictherapy: an effective alternative approach to control fungal infections. Front Microbiol 2015; 6: 202-212
23. Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005; 104(6): 1322-1331
24. Chun YS, et al. Intraductal administration of a polymeric nanoparticle formulation of curcumin (Nano Cure) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populations. Carcinogenesis 2012; 33 (11): 2242-2249
25. Hu L, et al. Preparation and Enhancement of Oral Bioavailability of Curcumin Using Microemulsions Vehicle. J Agric Food Chem 2012; 60 (29): 7137-7141
26. Baltazar LM, et al. Trichophyton rubrum is inhibited by free and nanoparticle encapsulated curcumin by induction of nitrosative stress after photodynamic activation. PLoS ONE 2015; 10(3):e0120179
27. Radi R, Cassina A, Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 2002; 383:401-409
28. Carmello JC, Pavarina AC, Oliveira R, Johansson B. Genotoxic effect of photodynamictherapy mediated by curcumin on Candida albicans. FEMS Yeast Research 2015; 15(4):fov018
29. Zhang C, et al. Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-jB signaling. Journal of Investigative Dermatology 2010; 130:2110-2119
30. Sunagawa Y, Katanasaka Y, Hasegawa K, Morimoto T. Clinical applications of curcumin. Pharma Nutrition 2015; 3(4): 131-135
31. Balasubramanyam K, et al. Curcumin, a novel p300/ CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004; 279 (49): 51163-71
32. Sunagawa Y, et al. A natural рЗОО-specific histone acetyltransferase inhibitor, curcumin, in addi-tion to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats. CircJ2011;75(9):2151-9
33. Nakagawa Y, Mukai S, Yamada S, Matsuoka M. Short-term effects of highly- bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study. J Orthop Sci 2014; 19 (6): 933-9
34. Joe B, Vijaykumar M, Lokesh B. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 2004; 44: 97-111.